chr19-2246771-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The ENST00000221494.10(SF3A2):c.374C>T(p.Ser125Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000527 in 1,613,928 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000221494.10 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SF3A2 | NM_007165.5 | c.374C>T | p.Ser125Leu | missense_variant | 6/9 | ENST00000221494.10 | NP_009096.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SF3A2 | ENST00000221494.10 | c.374C>T | p.Ser125Leu | missense_variant | 6/9 | 1 | NM_007165.5 | ENSP00000221494 | P1 | |
SF3A2 | ENST00000586396.2 | c.374C>T | p.Ser125Leu | missense_variant | 6/6 | 3 | ENSP00000466634 | |||
SF3A2 | ENST00000587637.2 | n.66C>T | non_coding_transcript_exon_variant | 2/2 | 2 | |||||
SF3A2 | ENST00000592314.5 | n.453C>T | non_coding_transcript_exon_variant | 6/8 | 5 |
Frequencies
GnomAD3 genomes AF: 0.000230 AC: 35AN: 152102Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000558 AC: 14AN: 250712Hom.: 0 AF XY: 0.0000737 AC XY: 10AN XY: 135722
GnomAD4 exome AF: 0.0000342 AC: 50AN: 1461708Hom.: 0 Cov.: 34 AF XY: 0.0000399 AC XY: 29AN XY: 727154
GnomAD4 genome AF: 0.000230 AC: 35AN: 152220Hom.: 0 Cov.: 33 AF XY: 0.000255 AC XY: 19AN XY: 74422
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 12, 2021 | The c.374C>T (p.S125L) alteration is located in exon 6 (coding exon 5) of the SF3A2 gene. This alteration results from a C to T substitution at nucleotide position 374, causing the serine (S) at amino acid position 125 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at